Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
The clonoSEQ® Watch Registry
- Status
- TERMINATED
- Phase
- N/A
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Diet, Physical Activity and Body Composition Changes During R-CHOP
- Status
- WITHDRAWN
- Phase
- N/A
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Status
- RECRUITING
- Phase
- PHASE2
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
- Status
- TERMINATED
- Phase
- NA
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA